Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Chella

Showing results (81-90 of 112) with videos related to

Pageof 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatmentAntonio Marchetti, Carla Martella, Lara Felicioni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Int6 expression can predict survival in early-stage non-small cell lung cancer patientsFiamma Buttitta, Carla Martella, Fabio Barassi, et al.
Clinical Lung Cancer|November 19, 2019
Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNAMarzia Del Re, Iacopo Petrini, Francesca Mazzoni, et al.
Human Mutation|February 23, 2008
Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lungAntonio Marchetti, Lara Felicioni, Giuseppe Pelosi, et al.
Journal of Thoracic Disease|January 7, 2022
Stereotactic body radiation therapy for the treatment of pleural metastases in patients with thymoma: a retrospective review of 22 patientsGiulia Pasquini, Claudia Menichelli, Gabriella Pastore, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2015
microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancersPierluigi Gasparini, Luciano Cascione, Lorenza Landi, et al.
Plos One|August 20, 2014
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatmentAntonio Marchetti, Maela Del Grammastro, Lara Felicioni, et al.
International Journal of Cancer|September 22, 2006
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar featuresFiamma Buttitta, Fabio Barassi, Giuseppina Fresu, et al.
Cancers|April 13, 2024
Early-Stage Non-Small Cell Lung Cancer: Prevalence of Actionable Alterations in a Monocentric Consecutive CohortRossella Bruno, Anello Marcello Poma, Martina Panozzi, et al.
European Thyroid Journal|May 27, 2022
Steroid treatment in the management of destructive thyrotoxicosis induced by PD1 blockadeAlessandro Brancatella, Laura Pierotti, Nicola Viola, et al.
Pageof 12

Showing results (81-90 of 112) with videos related to

Sort By:
Pageof 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatmentAntonio Marchetti, Carla Martella, Lara Felicioni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Int6 expression can predict survival in early-stage non-small cell lung cancer patientsFiamma Buttitta, Carla Martella, Fabio Barassi, et al.
Clinical Lung Cancer|November 19, 2019
Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNAMarzia Del Re, Iacopo Petrini, Francesca Mazzoni, et al.
Human Mutation|February 23, 2008
Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lungAntonio Marchetti, Lara Felicioni, Giuseppe Pelosi, et al.
Journal of Thoracic Disease|January 7, 2022
Stereotactic body radiation therapy for the treatment of pleural metastases in patients with thymoma: a retrospective review of 22 patientsGiulia Pasquini, Claudia Menichelli, Gabriella Pastore, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2015
microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancersPierluigi Gasparini, Luciano Cascione, Lorenza Landi, et al.
Plos One|August 20, 2014
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatmentAntonio Marchetti, Maela Del Grammastro, Lara Felicioni, et al.
International Journal of Cancer|September 22, 2006
Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar featuresFiamma Buttitta, Fabio Barassi, Giuseppina Fresu, et al.
Cancers|April 13, 2024
Early-Stage Non-Small Cell Lung Cancer: Prevalence of Actionable Alterations in a Monocentric Consecutive CohortRossella Bruno, Anello Marcello Poma, Martina Panozzi, et al.
European Thyroid Journal|May 27, 2022
Steroid treatment in the management of destructive thyrotoxicosis induced by PD1 blockadeAlessandro Brancatella, Laura Pierotti, Nicola Viola, et al.
Pageof 12